Transfusion-dependent alpha-thalassemia

Clinical trials for Transfusion-dependent alpha-thalassemia explained in plain language.

Never miss a new study

Get alerted when new Transfusion-dependent alpha-thalassemia trials appear

Sign up with your email to follow new studies for Transfusion-dependent alpha-thalassemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New pill may cut transfusions for thalassemia patients

Disease control Ongoing

This phase 3 study tests whether mitapivat, an oral medication, can safely reduce the number of blood transfusions needed by adults with transfusion-dependent alpha- or beta-thalassemia. Participants receive either mitapivat or a placebo for 48 weeks. The main goal is to see if m…

Matched conditions: TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA

Phase 3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC

Transfusion-dependent alpha-thalassemia

Get alerted when new Transfusion-dependent alpha-thalassemia trials appear

New pill may cut transfusions for thalassemia patients